Allogenic Dendritic Cells

PreclinicalSmall molecule

NNational Institute of Allergy and Infectious Diseases (NIAID)

Allogenic Dendritic Cells is one of 6 small molecule programs targeting Dendritic Cell. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Dendritic CellTerminated

Dendritic CellPreclinical

Terminated

Competition

Competitive Landscape

5 competitors in Dendritic Cell

#DrugCompanyPhaseTrials

Perjeta

Roche

Phase 2

1 2

Taxol

Teva

Phase 2

1 3

Herceptin

OOrganon and Co

Phase 2

1 4

Interleukin 2

EEssen Biotech

Phase 2

1 5

HER-2 Pulsed DC1

HH. Lee Moffitt Cancer Center and Research Institute

Phase 2

1 6

Allogenic Dendritic Cells

NNational Institute of Allergy and Infectious Diseases (NIAID)

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Kidney Transplant1 trial

Efficacy of Islet After Kidney Transplantation

Completed·NNational Institute of Allergy and Infectious Diseases (NIAID)·Phase 3·NCT00468117·24 enrolled

Dendritic Cell1 trial

A Pilot Study of Immunization With HIV-1 Antigen Pulsed Allogenic Dendritic Cells in HIV-Infected Asymptomatic Patients With CD4+ T Cells > 350 Cells/mm3

Terminated·NNational Institute of Allergy and Infectious Diseases (NIAID)·N/A·NCT00001064

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for Allogenic Dendritic Cells. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Allogenic Dendritic Cells compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Allogenic Dendritic Cells. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — National Institute of Allergy and Infectious Diseases (NIAID) company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: NNational Institute of Allergy and Infectious Diseases (NIAID)

Allogenic Dendritic Cells

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Kidney Transplant1 trial

Dendritic Cell1 trial

References

Drug Info

Quick Facts

Related News